Загрузка...
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
Oral administration of sapropterin hydrochloride, recently approved for use by the US Food and Drug Administration and the European Commission, is a novel approach for the treatment of phenylketonuria (PKU), one of the most common inborn errors of metabolism. PKU is caused by an inherited deficiency...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921259/ https://ncbi.nlm.nih.gov/pubmed/20714359 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|